Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China · Delayed Price · Currency is CNY 4.150
-0.010 (-0.24%)
Feb 4, 2026, 1:15 PM CST
SHE:002424 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 2.22 | 33.62 | -414.51 | 138.47 | 118.48 | 152.38 |
Depreciation & Amortization | 115.44 | 115.44 | 116.66 | 116.16 | 107.01 | 96.48 |
Other Amortization | 9.52 | 9.52 | 7.58 | 7.32 | 6.77 | 20.56 |
Loss (Gain) From Sale of Assets | 0.14 | 0.14 | -1.14 | 0.3 | 0.47 | -0.07 |
Asset Writedown & Restructuring Costs | 23.22 | 23.22 | 126.85 | -0.9 | 0.92 | 0.49 |
Loss (Gain) From Sale of Investments | 34.69 | 34.69 | 9.82 | -38.73 | -58.53 | -36.34 |
Provision & Write-off of Bad Debts | - | - | - | 60.47 | 66.48 | 100.94 |
Other Operating Activities | 699.4 | 88.98 | 88.9 | 138.73 | 104.78 | 134.39 |
Change in Accounts Receivable | 477.34 | 477.34 | -34.97 | -182.7 | 193.73 | -163.74 |
Change in Inventory | -4.2 | -4.2 | -396.58 | 8.74 | -70.21 | 221.06 |
Change in Accounts Payable | -746.94 | -746.94 | 734.65 | 220.91 | -95.77 | 33.31 |
Change in Other Net Operating Assets | - | - | - | 46.12 | -46.12 | - |
Operating Cash Flow | 588.04 | 9.02 | 125.77 | 502.15 | 324.92 | 544.41 |
Operating Cash Flow Growth | 271.43% | -92.83% | -74.95% | 54.55% | -40.32% | 16.47% |
Capital Expenditures | 9.1 | -42.02 | -104.12 | -68.45 | -425.73 | -90.02 |
Sale of Property, Plant & Equipment | 0.21 | 0.06 | 1.46 | 0.78 | 0.12 | 0.15 |
Cash Acquisitions | - | - | -3.92 | - | - | - |
Divestitures | - | - | - | - | - | -31.4 |
Investment in Securities | 117.42 | 133.8 | 63.32 | 80.75 | -162.07 | 10.09 |
Other Investing Activities | 10.72 | -11.32 | 8.43 | 7.33 | 282.47 | -337.43 |
Investing Cash Flow | 137.45 | 80.52 | -34.83 | 20.44 | 42.59 | -517.37 |
Short-Term Debt Issued | - | - | - | - | 1,546 | - |
Long-Term Debt Issued | - | 1,627 | 1,698 | 1,480 | 90 | 2,351 |
Total Debt Issued | 1,155 | 1,627 | 1,698 | 1,480 | 1,636 | 2,351 |
Long-Term Debt Repaid | - | -1,595 | -1,733 | -1,710 | -2,202 | -2,360 |
Total Debt Repaid | -1,836 | -1,595 | -1,733 | -1,710 | -2,202 | -2,360 |
Net Debt Issued (Repaid) | -681.06 | 31.89 | -34.69 | -229.73 | -566.01 | -9 |
Issuance of Common Stock | - | - | - | - | - | 82.9 |
Repurchase of Common Stock | -119.58 | -119.58 | -100.01 | - | -100.2 | - |
Common Dividends Paid | -60.38 | -81.35 | -80.54 | -86.55 | -100.18 | -431.57 |
Other Financing Activities | 136.57 | - | 0.43 | 1 | - | -53.7 |
Financing Cash Flow | -724.45 | -169.04 | -214.81 | -315.28 | -766.39 | -411.37 |
Foreign Exchange Rate Adjustments | -0 | 0 | -0 | 0 | -0 | - |
Net Cash Flow | 1.04 | -79.5 | -123.87 | 207.31 | -398.89 | -384.33 |
Free Cash Flow | 597.14 | -33 | 21.65 | 433.7 | -100.81 | 454.39 |
Free Cash Flow Growth | 467.29% | - | -95.01% | - | - | 31.51% |
Free Cash Flow Margin | 18.95% | -0.86% | 0.51% | 12.25% | -3.24% | 14.71% |
Free Cash Flow Per Share | 0.36 | -0.02 | 0.02 | 0.31 | -0.07 | 0.33 |
Cash Income Tax Paid | 334.74 | 398.79 | 455.21 | 370.44 | 311.21 | 348.19 |
Levered Free Cash Flow | 1,272 | 106.62 | 412.39 | 464.92 | 245.79 | 293.18 |
Unlevered Free Cash Flow | 1,312 | 160.27 | 469.63 | 528.46 | 318.45 | 375.25 |
Change in Working Capital | -296.58 | -296.58 | 191.61 | 80.33 | -21.46 | 75.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.